# Allogene Therapeutics, Inc.: Form 4, filed Oct 23, 2026

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 4
- Filed: 2026-10-23
- Accepted by EDGAR: Oct 23, 2026, 16:48 ET
- Period: 2026-10-21
- Accession: 0001491874-26-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000149187426000005/xslF345X06/wk-form4_1792788493.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000149187426000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000149187426000005/xslF345X06/wk-form4_1792788493.xml

Filed Oct 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001491874-26-000005. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.